- Patent Title: Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
-
Application No.: US13988925Application Date: 2011-11-24
-
Publication No.: US10023847B2Publication Date: 2018-07-17
- Inventor: Jean-Marie Saint-Remy
- Applicant: Jean-Marie Saint-Remy
- Applicant Address: LU Strassen
- Assignee: IMNATE SARL
- Current Assignee: IMNATE SARL
- Current Assignee Address: LU Strassen
- Agency: Clark & Elbing LLP
- Priority: EP10192559 20101125
- International Application: PCT/EP2011/070898 WO 20111124
- International Announcement: WO2012/069568 WO 20120531
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K35/17 ; A61K39/35 ; A61K39/385 ; C12N5/0783 ; C12N9/02 ; C12N9/90 ; A61K39/12 ; C07H21/00
Abstract:
The invention describes new peptides containing epitopes recognized by CD4+ natural killer T (NKT) cells for increasing activity for use in infectious diseases, autoimmune diseases, immune reaction to administration of allofactors, allergic diseases, therapy of tumors, prevention of graft rejection and prevention of immunization against viral proteins used in gene therapy or gene vaccination.
Public/Granted literature
Information query
